Measles cases in 2026?
$0.00
1
5
Measles cases in 2026?
$0.00
1
5
AI Analysis
Trader mode: Actionable analysis for identifying opportunities and edge
About This Event
In 2026 If the number of measles in 2026 is above X then the market resolves to Yes. Early close condition: If this event occurs, the market will close the following 10am ET. If this event occurs, the market will close the following 10am ET.
Current Market Outlook
Kalshi traders are pricing an 88% probability that the United States will record more than 3,000 measles cases in 2026. That is a high-confidence bet. For context, the U.S. averaged roughly 100–200 measles cases per year between 2001 and 2018. The last time the annual count exceeded 3,000 was 1992, when 2,237 cases were reported. The market is essentially saying that 2026 will be the worst measles year in over three decades.
Key Factors Driving the Odds
The primary driver is the ongoing decline in childhood vaccination rates. The CDC reported that kindergarten MMR exemption rates hit 3.3% in the 2023–2024 school year, the highest on record. That might sound small, but measles is the most contagious known virus. At 3% exemption in a population with imperfect coverage elsewhere, herd immunity breaks down.
The second factor is the current 2025 outbreak trajectory. As of late 2025, the U.S. had already logged over 800 cases, concentrated in undervaccinated communities in Ohio, Texas, and Florida. If that pace continues through 2026, 3,000 cases is not an outlier projection. It is a linear extrapolation of what is already happening.
The third factor is political. Robert F. Kennedy Jr., a prominent vaccine skeptic, has been floated for a health policy role in a potential second Trump administration. Even if that does not materialize, the anti-vaccine movement has shifted from fringe to mainstream in parts of the GOP base. State-level exemption laws are being loosened, not tightened.
What Could Change These Odds
A major outbreak in 2025 that kills children could shift public opinion and trigger emergency vaccination campaigns. That would push 2026 cases down sharply. Conversely, if the 2025 outbreak is contained and the public grows complacent, 2026 could see even higher numbers.
The key date to watch is January 2026, when the CDC releases its final 2025 case count. If that number is above 1,500, the 88% probability will look cheap. If it is below 500, the market could reprice to 50% or lower.
Cross-Platform Analysis
Only Kalshi is trading this contract. Polymarket has no equivalent. That limits arbitrage opportunities but also means the price reflects a single pool of mostly U.S.-based traders who may be influenced by domestic media coverage. If a global health agency like the WHO issued a warning about U.S. measles resurgence in early 2026, the price could jump quickly with no cross-platform hedge available.
AI-generated analysis based on market data. Not financial advice.
Overview
Measles is a highly contagious viral disease that can cause severe complications, including pneumonia, encephalitis, and death. Despite the availability of a safe and effective vaccine since the 1960s, measles remains a global health threat due to gaps in vaccination coverage. The prediction market question asks whether the number of measles cases in 2026 will exceed a certain threshold, reflecting concerns about resurgent outbreaks driven by declining immunization rates, vaccine hesitancy, and disruptions caused by the COVID-19 pandemic. Measles is one of the most infectious known pathogens, with a basic reproduction number (R0) of 12 to 18, meaning one infected person can spread the virus to many others in a susceptible population. The World Health Organization (WHO) and the U.S. Centers for Disease Control and Prevention (CDC) track cases globally and nationally, providing data used to assess progress toward elimination goals. In recent years, measles cases have spiked in various regions, including a 79% increase globally in 2023 compared to 2022, according to WHO estimates. The United States, which declared measles eliminated in 2000, has seen a rise in outbreaks linked to imported cases and unvaccinated communities. In 2024, the U.S. reported over 200 cases by mid-year, a pace that could lead to the highest annual total since 2019. The outcome for 2026 depends on factors such as vaccination campaign effectiveness, public health policies, and the spread of misinformation. People are interested in this topic because measles resurgence signals broader weaknesses in public health infrastructure and the consequences of vaccine hesitancy, which have implications for other vaccine-preventable diseases. The prediction market allows participants to bet on a specific numeric outcome, making it a focused way to gauge collective expectations about future public health trends.
Historical Context
Measles has been a human disease for over a thousand years, with the first scientific description by Persian physician Rhazes in the 9th century. Before the vaccine was introduced in 1963, measles caused an estimated 2.6 million deaths annually worldwide, according to WHO. In the United States, before the vaccine, nearly all children got measles by age 15, with 400 to 500 deaths each year, 48,000 hospitalizations, and 1,000 cases of encephalitis. The measles vaccine, first licensed in 1963 and later combined into the MMR (measles, mumps, rubella) vaccine in 1971, dramatically reduced cases. By 2000, the U.S. declared measles eliminated, meaning no continuous transmission for 12 months. Globally, measles deaths fell by 73% between 2000 and 2018, from over 540,000 to 142,000, according to WHO and UNICEF estimates. However, progress stalled after 2016. In 2019, the world saw a resurgence, with over 869,000 cases reported, the highest in 23 years. Major outbreaks occurred in the Democratic Republic of the Congo (over 300,000 cases), Madagascar (over 200,000 cases), and Ukraine (over 57,000 cases). The COVID-19 pandemic then disrupted vaccination campaigns, with 23 million children missing their first measles vaccine dose in 2020, the largest increase in two decades. This led to a 79% increase in global measles cases in 2022 compared to 2021, with 37 countries experiencing large or disruptive outbreaks. The historical pattern shows that measles rebounds quickly when vaccination coverage falls below the 95% threshold needed for herd immunity.
Why It Matters
The number of measles cases in 2026 matters because it serves as a barometer for global public health system resilience. Measles is often called the 'canary in the coal mine' for vaccine-preventable diseases, as it is the most contagious and the first to resurge when immunity gaps appear. A high case count would indicate that efforts to recover from pandemic-era vaccination disruptions have failed, potentially leading to increased child mortality and long-term health complications. The economic impact includes direct healthcare costs for treating complications like pneumonia and encephalitis, plus broader costs from lost productivity and outbreak containment. For example, a single U.S. measles outbreak in 2019 cost local health departments an estimated $3.4 million per outbreak, according to a CDC study. Politically, a measles surge could fuel debates over vaccine mandates, school immunization requirements, and public health funding. Socially, it would highlight the real-world consequences of vaccine hesitancy, which has been amplified by misinformation on social media platforms. Children under five and immunocompromised individuals are most at risk. The downstream consequences include potential strain on hospital systems, increased antibiotic use for secondary infections, and erosion of trust in public health institutions if outbreaks become routine.
Current Status
As of late 2024, measles cases are rising globally and in the U.S. The WHO reported over 300,000 confirmed cases globally in 2023, and early 2024 data shows continued high transmission in countries like Yemen, India, and Pakistan. In the United States, the CDC reported 212 measles cases across 20 states as of October 2024, with outbreaks in Chicago, Florida, and Ohio. This pace is similar to 2019, when the U.S. saw 1,282 cases. Vaccination coverage in the U.S. for kindergarteners dropped to 93% in the 2022-2023 school year, below the 95% target, according to CDC data. Globally, the WHO and UNICEF launched a 'Big Catch-Up' campaign in 2023 to vaccinate children missed during the pandemic, but funding shortfalls and conflict zones have limited progress. The prediction market for 2026 cases is influenced by these trends, as well as potential new vaccine policies or outbreaks.
Frequently Asked Questions
How many measles cases were there in 2023 globally?
The WHO reported over 300,000 confirmed measles cases in 2023, a 79% increase from 2022. However, the actual number is likely higher due to underreporting, with estimates suggesting over 9 million cases and 136,000 deaths.
What is the herd immunity threshold for measles?
The herd immunity threshold for measles is 95% vaccination coverage, because the virus is highly contagious with an R0 of 12 to 18. Below this level, outbreaks can occur in unvaccinated pockets.
Educational content is AI-generated and sourced from Wikipedia. It should not be considered financial advice.
